China-U.S. Seminar on Medical Device Regulatory Science and Legislation Held

  • 2023-12-19
On the afternoon of December 15, the China-U.S. Seminar on Medical Device Regulatory Science and Legislation was held in Beijing. Xu Jinghe, the member of Party Group and the Deputy Director of the National Medical Products Administration, attended the meeting and gave a speech.


Xu Jinghe said that the National Medical Products Administration (NMPA) attaches great importance to the construction of the medical device regulatory system, encourages and supports the innovation and development of medical devices, and has approved a total of 256 innovative medical device products to be marketed so far, and the public's demand for devices has been better met. It is hoped that under the framework of the cooperation program between China and the U.S. drug regulatory agencies, the two sides will further expand cooperation in medical device to better serve the health of the people in the two countries.

At the Seminar, representatives of the NMPA introduced the implementation of the revised Regulation on the Supervision and Administration of Medical Devices as well as the establishment of standards for medical devices in China.

Representatives from the U.S. Food and Drug Administration (FDA) Office in China introduced U.S. laws, regulations and legislative procedures related to medical devices, as well as key areas and specific issues in medical device regulatory science.

Relevant departments of the NMPA and units directly under the NMPA sent staff to attend the Seminar.

Source: National Medical Products Administration